BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6466633)

  • 21. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.
    Coller BS; Peerschke EI; Scudder LE; Sullivan CA
    J Clin Invest; 1983 Jul; 72(1):325-38. PubMed ID: 6308050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycoprotein IIb-IIIa and the translocation of Rap2B to the platelet cytoskeleton.
    Torti M; Ramaschi G; Sinigaglia F; Lapetina EG; Balduini C
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4239-43. PubMed ID: 8183895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of alternative mechanisms of collagen-induced platelet activation by using monoclonal antibodies to glycoprotein IIb-IIIa and fibrinogen.
    Connellan JM; Thurlow PJ; Barlow B; Lowe M; McKenzie IF
    Thromb Haemost; 1986 Apr; 55(2):153-7. PubMed ID: 2940722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.
    De Marco L; Girolami A; Russell S; Ruggeri ZM
    J Clin Invest; 1985 Apr; 75(4):1198-203. PubMed ID: 3157702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The murine lymphocyte receptor for IgE. III. Use of chemical cross-linking reagents to further characterize the B lymphocyte Fc epsilon receptor.
    Lee WT; Conrad DH
    J Immunol; 1985 Jan; 134(1):518-25. PubMed ID: 3155470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-hydroxysulfosuccinimide active esters: bis(N-hydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers.
    Staros JV
    Biochemistry; 1982 Aug; 21(17):3950-5. PubMed ID: 7126526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of extracellular calcium with the platelet membrane glycoprotein IIb-IIIa complex.
    Shattil SJ; Brass LF
    Nouv Rev Fr Hematol (1978); 1985; 27(4):211-7. PubMed ID: 2997701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion.
    Moroi M; Jung SM; Okuma M; Shinmyozu K
    J Clin Invest; 1989 Nov; 84(5):1440-5. PubMed ID: 2808700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins.
    Golden A; Brugge JS; Shattil SJ
    J Cell Biol; 1990 Dec; 111(6 Pt 2):3117-27. PubMed ID: 1702789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reassociation and translocation of glycoprotein IIB-IIIA in EDTA-treated human platelets.
    Ma Y; Wong K
    Platelets; 2007 Sep; 18(6):451-9. PubMed ID: 17763154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation.
    Modderman PW; Huisman HG; van Mourik JA; von dem Borne AE
    Thromb Haemost; 1988 Aug; 60(1):68-74. PubMed ID: 2973154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.
    De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
    Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L
    Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexpected products from the reaction of the synthetic cross-linker 3,3'-dithiobis(sulfosuccinimidyl propionate), DTSSP with peptides.
    Swaim CL; Smith JB; Smith DL
    J Am Soc Mass Spectrom; 2004 May; 15(5):736-49. PubMed ID: 15121203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of extra- and intracellular calcium chelation on human platelet function and glycoprotein IIb-IIIa complex stability.
    Lanza F; Stierlé A; Gachet C; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1992; 34(1):123-31. PubMed ID: 1523093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metalloprotease, NN-PF3 from Naja naja venom inhibits platelet aggregation primarily by affecting α2β1 integrin.
    Kumar MS; Girish KS; Vishwanath BS; Kemparaju K
    Ann Hematol; 2011 May; 90(5):569-77. PubMed ID: 20957364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane-impermeant cross-linking reagents for structural and functional analyses of platelet membrane glycoproteins.
    Staros JV; Kotite NJ; Cunningham LW
    Methods Enzymol; 1992; 215():403-12. PubMed ID: 1435336
    [No Abstract]   [Full Text] [Related]  

  • 39. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
    Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
    J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.